JPS5531159A
(en)
|
1978-08-26 |
1980-03-05 |
Sumitomo Metal Ind Ltd |
Manufacture of high strength cold rolled steel plate for press working
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
*
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4510245A
(en)
*
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
US4504586A
(en)
*
|
1983-02-03 |
1985-03-12 |
Amgen |
Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1
|
US4740461A
(en)
*
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
AU594045B2
(en)
*
|
1985-02-05 |
1990-03-01 |
Chiron Corporation |
Recombinant colony stimulating factor-1
|
US4847201A
(en)
*
|
1985-02-05 |
1989-07-11 |
Cetus Corporation |
DNA encoding for CSF-1 and accompanying recombinant systems
|
US5573930A
(en)
|
1985-02-05 |
1996-11-12 |
Cetus Oncology Corporation |
DNA encoding various forms of colony stimulating factor-1
|
US5792450A
(en)
*
|
1985-02-05 |
1998-08-11 |
Chiron Corporation |
Purified human CSF-1
|
US6146851A
(en)
|
1985-02-05 |
2000-11-14 |
Chiron Corporation |
DNA encoding NV2 (long form) and carboxy truncated fragments thereof
|
US5837229A
(en)
|
1985-02-05 |
1998-11-17 |
Chiron Corporation |
Uses of recombinant colony stimulating factor-1
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
US4868119A
(en)
*
|
1986-12-11 |
1989-09-19 |
Genetics Institute, Inc. |
Hematopoietic growth factors
|
MX9203130A
(es)
*
|
1986-05-06 |
1992-07-01 |
Genetics Inst |
Produccion de m-csf
|
US4959455A
(en)
*
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
GB8624899D0
(en)
|
1986-10-17 |
1986-11-19 |
Sandoz Ltd |
Monoclonal antibodies
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
CA1339757C
(en)
*
|
1987-04-16 |
1998-03-17 |
Robert F. Halenbeck |
Production of purified biologically active, bacterially produced recombinant human csf-1
|
US4929700A
(en)
*
|
1987-04-16 |
1990-05-29 |
Cetus Corporation |
Production of purified, biologically active, bacterially produced recombinant human CSF-1
|
US5750172A
(en)
|
1987-06-23 |
1998-05-12 |
Pharming B.V. |
Transgenic non human mammal milk
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
US4929455A
(en)
*
|
1988-07-07 |
1990-05-29 |
Mallinckrodt, Inc. |
Flour-based pot pie crusts with improved texture
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
DK0457804T3
(da)
*
|
1989-02-10 |
1996-09-23 |
Chiron Corp |
M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
|
CA2062975A1
(en)
|
1989-07-14 |
1991-01-15 |
Gail F. Seelig |
Antagonists of gm-csf derived from the carboxyl terminus
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
EP0506855A1
(en)
*
|
1989-12-15 |
1992-10-07 |
Chiron Corporation |
Cytokine antibody for the treatment of sepsis
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5151510A
(en)
*
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
EP0546091B1
(en)
|
1990-08-29 |
2007-01-24 |
Pharming Intellectual Property BV |
Homologous recombination in mammalian cells
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US7084260B1
(en)
*
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
US5789650A
(en)
*
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US6300129B1
(en)
*
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US6255458B1
(en)
*
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5814318A
(en)
*
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
EP0814159B1
(en)
*
|
1990-08-29 |
2005-07-27 |
GenPharm International, Inc. |
Transgenic mice capable of producing heterologous antibodies
|
US7041871B1
(en)
*
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
CA2060741A1
(en)
|
1991-02-11 |
1992-08-12 |
Robert S. Greenfield |
Gm-csf inhibiting oligopeptides
|
AU1545692A
(en)
|
1991-03-01 |
1992-10-06 |
Protein Engineering Corporation |
Process for the development of binding mini-proteins
|
ATE269401T1
(de)
|
1991-04-10 |
2004-07-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
WO1993004169A1
(en)
*
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
DK0605522T3
(da)
|
1991-09-23 |
2000-01-17 |
Medical Res Council |
Fremgangsmåde til fremstilling af humaniserede antistoffer
|
JPH0595794A
(ja)
*
|
1991-10-04 |
1993-04-20 |
Otsuka Pharmaceut Co Ltd |
ヒトm−csf抗体及びヒトm−csfの測定法
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
JPH08503121A
(ja)
|
1991-12-10 |
1996-04-09 |
デイナ・フアーバー・キヤンサー・インステイテユート |
中和反応性ヒト抗−gp120組換え抗体、それをコードするdnaおよびその使用
|
JPH067189A
(ja)
|
1991-12-17 |
1994-01-18 |
Morinaga Milk Ind Co Ltd |
ヒトM−CSF β型ダイマ−に特異性を有するモノクロ− ナル抗体と、この抗体を産生するハイブリドーマ、お よびこの抗体の利用
|
AU675929B2
(en)
*
|
1992-02-06 |
1997-02-27 |
Curis, Inc. |
Biosynthetic binding protein for cancer marker
|
DE69329247T2
(de)
*
|
1992-06-09 |
2001-05-31 |
Chiron Corp |
Kristallisierung von m-csf
|
JPH07509137A
(ja)
|
1992-07-24 |
1995-10-12 |
セル ジェネシス,インク. |
異種抗体の生産
|
JP3714683B2
(ja)
*
|
1992-07-30 |
2005-11-09 |
生化学工業株式会社 |
抗リウマチ剤
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
JPH06194367A
(ja)
|
1992-12-25 |
1994-07-15 |
Morinaga Milk Ind Co Ltd |
リウマチ疾患の診断方法
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
PT804070E
(pt)
*
|
1993-03-09 |
2000-11-30 |
Genzyme Corp |
Isolamento de componentes de interesse a partir do leite.
|
JPH06319584A
(ja)
|
1993-05-07 |
1994-11-22 |
Morinaga Milk Ind Co Ltd |
抗m−csfモノクロ−ナル抗体と、この抗体を産生 するハイブリド−マ
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
WO1995029690A1
(en)
*
|
1994-04-29 |
1995-11-09 |
The Trustees Of The University Of Pennsylvania |
Biologically active peptides and methods of identifying the same
|
US5643763A
(en)
*
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
US6046037A
(en)
*
|
1994-12-30 |
2000-04-04 |
Hiatt; Andrew C. |
Method for producing immunoglobulins containing protection proteins in plants and their use
|
US5863949A
(en)
*
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
US6091001A
(en)
*
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6130364A
(en)
*
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US5861510A
(en)
|
1995-04-20 |
1999-01-19 |
Pfizer Inc |
Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors
|
JPH11503914A
(ja)
|
1995-04-21 |
1999-04-06 |
セル ジェネシス,インコーポレイテッド |
大ゲノムdna欠失の生成
|
EP1709970A1
(en)
|
1995-04-27 |
2006-10-11 |
Abgenix, Inc. |
Human antibodies against EGFR, derived from immunized xenomice
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5880141A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
GB9520822D0
(en)
|
1995-10-11 |
1995-12-13 |
Wellcome Found |
Therapeutically active compounds
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
ATE225343T1
(de)
|
1995-12-20 |
2002-10-15 |
Hoffmann La Roche |
Matrix-metalloprotease inhibitoren
|
NZ331191A
(en)
|
1996-03-05 |
2000-03-27 |
Zeneca Ltd |
4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
|
US5714352A
(en)
*
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
US5994619A
(en)
|
1996-04-01 |
1999-11-30 |
University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus |
Production of chimeric bovine or porcine animals using cultured inner cell mass cells
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
PT912559E
(pt)
|
1996-07-13 |
2003-03-31 |
Glaxo Group Ltd |
Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
|
BR9710362A
(pt)
|
1996-07-13 |
1999-08-17 |
Glaxo Group Ltd |
Composto formula-ao farmaceutica utiliza-ao de um composto processos de tratamento de um ser humano ou animal sofrendo de uma mediada por atividade anormal de cinase de proteina tirosina e para a prepara-ao de um composto
|
BR9710381A
(pt)
|
1996-07-18 |
1999-08-17 |
Pfizer |
Inibidores de metaloproteases de matriz - base de fosfinato
|
JP2000501423A
(ja)
|
1996-08-23 |
2000-02-08 |
ファイザー インク. |
アリールスルホニルアミノヒドロキサム酸誘導体
|
ID18494A
(id)
|
1996-10-02 |
1998-04-16 |
Novartis Ag |
Turunan pirazola leburan dan proses pembuatannya
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
ATE549918T1
(de)
*
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
US6077864A
(en)
|
1997-01-06 |
2000-06-20 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
PL335027A1
(en)
|
1997-02-03 |
2000-03-27 |
Pfizer Prod Inc |
Derivatives of arylsulphonylamino hydroxamic acid
|
BR9807824A
(pt)
|
1997-02-07 |
2000-03-08 |
Pfizer |
Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz
|
IL131123A0
(en)
|
1997-02-11 |
2001-01-28 |
Pfizer |
Arylsulfonyl hydroxamic acid derivatives
|
EP0968290B1
(en)
|
1997-03-12 |
2004-12-15 |
SmithKline Beecham Corporation |
Anti-alphavbeta3 humanized monoclonal antibodies
|
EP2336168A1
(en)
*
|
1997-04-15 |
2011-06-22 |
Sankyo Company Limited |
Novel protein and method for producing the protein
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
CA2289102A1
(en)
|
1997-05-07 |
1998-11-12 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
AU736549B2
(en)
|
1997-05-21 |
2001-08-02 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Method for the production of non-immunogenic proteins
|
AU734009B2
(en)
|
1997-05-30 |
2001-05-31 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
SK1362000A3
(en)
|
1997-08-08 |
2000-10-09 |
Pfizer Prod Inc |
Aryloxyarylsulfonylamino hydroxamic acid derivatives
|
DE69838172T2
(de)
|
1997-08-22 |
2008-04-10 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
WO1999016755A1
(en)
|
1997-09-26 |
1999-04-08 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
SK6652000A3
(en)
|
1997-11-11 |
2002-05-09 |
Pfizer Prod Inc |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
CA2322749A1
(en)
|
1998-03-03 |
1999-09-10 |
Abgenix, Inc. |
Cd147 binding molecules as therapeutics
|
JP4462654B2
(ja)
|
1998-03-26 |
2010-05-12 |
ソニー株式会社 |
映像素材選択装置及び映像素材選択方法
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
AU759226B2
(en)
|
1998-05-29 |
2003-04-10 |
Sugen, Inc. |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
AUPP525198A0
(en)
*
|
1998-08-13 |
1998-09-03 |
Medvet Science Pty. Ltd. |
Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
DE69915004T2
(de)
|
1998-11-05 |
2004-09-09 |
Pfizer Products Inc., Groton |
5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
|
JP2002534959A
(ja)
|
1998-12-08 |
2002-10-22 |
バイオベーション リミテッド |
免疫原性タンパク質の改変方法
|
WO2000035956A1
(fr)
*
|
1998-12-16 |
2000-06-22 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticorps monoclonal anti-vegf humain
|
IL143797A0
(en)
*
|
1998-12-23 |
2002-04-21 |
Pfizer |
Human monoclonal antibodies to cytotoxic t lymphocyte antigen 4
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
US6471429B1
(en)
*
|
1999-01-29 |
2002-10-29 |
Canon Kabushiki Kaisha |
Sheet processing apparatus for discharging sheets in a bundle
|
AU5761900A
(en)
|
1999-06-30 |
2001-01-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Human monoclonal antibodies to hiv-1 envelope glycoprotein gp120
|
WO2001014424A2
(en)
|
1999-08-24 |
2001-03-01 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
US6794132B2
(en)
*
|
1999-10-02 |
2004-09-21 |
Biosite, Inc. |
Human antibodies
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
WO2001034177A2
(en)
|
1999-11-08 |
2001-05-17 |
The Government Of The United States Of America, A S Represented By The Secretary, Department Of Hea Lth & Human Services, The National Institutes Of Health |
Method of treating a viral infection using antagonists of macrophage colony stimulating factor
|
US6517529B1
(en)
|
1999-11-24 |
2003-02-11 |
Radius International Limited Partnership |
Hemodialysis catheter
|
US6680209B1
(en)
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
US20030232054A1
(en)
|
2000-01-25 |
2003-12-18 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
EP1285084A1
(en)
|
2000-01-25 |
2003-02-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US7108852B2
(en)
*
|
2000-03-20 |
2006-09-19 |
Warner-Lambert Company Llc |
Methods of treating inflammation using antibodies to M-CSF
|
US20030059427A1
(en)
|
2000-04-28 |
2003-03-27 |
Force Walker R. |
Isolation and characterization of highly active anti-CD40 antibody
|
AU2001272925A1
(en)
*
|
2000-05-26 |
2001-12-11 |
Immunex Corporation |
Use of interleukin-4 antagonists and compositions thereof
|
AU6842701A
(en)
|
2000-06-16 |
2002-01-14 |
Human Genome Sciences Inc |
Antibodies that immunospecifically bind to blys
|
US7879328B2
(en)
*
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
US20040253242A1
(en)
|
2000-12-05 |
2004-12-16 |
Bowdish Katherine S. |
Rationally designed antibodies
|
US7396917B2
(en)
|
2000-12-05 |
2008-07-08 |
Alexion Pharmaceuticals, Inc. |
Rationally designed antibodies
|
WO2002059340A1
(en)
|
2001-01-26 |
2002-08-01 |
The Scripps Research Institute |
Immunopolypeptides to hepatitis c virus
|
US7192582B2
(en)
|
2001-02-12 |
2007-03-20 |
Medarex, Inc. |
Human monoclonal antibodies to FC alpha receptor (CD89)
|
US20020146753A1
(en)
*
|
2001-04-06 |
2002-10-10 |
Henrik Ditzel |
Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease
|
PT1391464E
(pt)
*
|
2001-04-27 |
2007-11-15 |
Kirin Pharma Kk |
Anticorpo monoclonal anti-cd40
|
JP4025881B2
(ja)
|
2001-04-27 |
2007-12-26 |
キリンファーマ株式会社 |
抗cd40モノクローナル抗体
|
FI112501B
(fi)
|
2001-05-18 |
2003-12-15 |
Valtion Teknillinen |
Heveiiniä sitovat monoklonaaliset vasta-aineet
|
CA2447602C
(en)
|
2001-05-18 |
2011-11-01 |
Kirin Beer Kabushiki Kaisha |
Anti-trail-r antibodies
|
JP2005168497A
(ja)
|
2001-05-18 |
2005-06-30 |
Kirin Brewery Co Ltd |
抗trail−r抗体およびその用途
|
US7171311B2
(en)
*
|
2001-06-18 |
2007-01-30 |
Rosetta Inpharmatics Llc |
Methods of assigning treatment to breast cancer patients
|
PT1410011E
(pt)
|
2001-06-18 |
2011-07-25 |
Rosetta Inpharmatics Llc |
Diagnóstico e prognóstico de pacientes com cancro da mama
|
US20040259153A1
(en)
|
2001-08-22 |
2004-12-23 |
Yoshikazu Kurosawa |
Methods for selecting biding molecule
|
JP3729841B2
(ja)
|
2001-10-15 |
2005-12-21 |
麒麟麦酒株式会社 |
抗hla−dr抗体の利用
|
JP3665324B2
(ja)
|
2001-10-15 |
2005-06-29 |
麒麟麦酒株式会社 |
抗hla−dr抗体
|
AU2002364954A1
(en)
|
2001-11-16 |
2003-07-15 |
Human Genome Sciences, Inc. |
ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
|
EP1461082A4
(en)
|
2001-12-03 |
2006-06-28 |
Abgenix Inc |
ANTIBODIES AGAINST THE TUMOR ANTIGEN OF CARBON IX ANHYDRASE (CA IX)
|
CA2467633C
(en)
|
2001-12-03 |
2012-03-27 |
Abgenix, Inc. |
Antibody categorization based on binding characteristics
|
EP1322146A1
(en)
|
2001-12-18 |
2003-06-25 |
Phoenix Precision Technology Corporation |
Method of electroplating solder bumps on an organic circuit board
|
NZ534174A
(en)
|
2002-01-09 |
2007-03-30 |
Medarex Inc |
An isolated human monoclonal antibody which binds to human CD30
|
CA2476625A1
(en)
|
2002-02-20 |
2003-08-28 |
Dyax Corp. |
Mhc-peptide complex binding ligands
|
CA2478386A1
(en)
|
2002-03-21 |
2003-10-02 |
Eli Lilly And Company |
Antagonistic anti-hfas ligand human antibodies and fragments thereof
|
CA2483337C
(en)
|
2002-04-23 |
2015-10-27 |
The Scripps Research Institute |
Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
|
CA2484155C
(en)
|
2002-04-29 |
2015-10-13 |
Baxter International Inc. |
Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
|
US20040110933A1
(en)
|
2002-09-13 |
2004-06-10 |
Dyax Corporation |
CD44-binding ligands
|
US7396913B2
(en)
*
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
ATE466885T1
(de)
*
|
2002-11-15 |
2010-05-15 |
Novartis Vaccines & Diagnostic |
Methoden zur verhinderung und behandlung von krebs-metastasierung und mit krebs-metastasierung einhergehendem knochenverlust
|
WO2004045512A2
(en)
|
2002-11-15 |
2004-06-03 |
Genmab A/S |
Human monoclonal antibodies against cd25
|
CL2003002461A1
(es)
|
2002-11-27 |
2005-01-07 |
Dow Chemical Company Agroscien |
Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
|
WO2004050032A2
(en)
|
2002-12-02 |
2004-06-17 |
Abgenix, Inc. |
Antibodies against drugs of abuse
|
MXPA05005925A
(es)
*
|
2002-12-02 |
2006-02-08 |
Abgenix Inc |
Anticuerpos dirigidos a la fosfolipasa a2 y sus usos.
|
US20050009136A1
(en)
*
|
2003-02-19 |
2005-01-13 |
Dyax Corporation |
PAPP-A ligands
|
CA2519528C
(en)
|
2003-03-19 |
2016-01-26 |
Abgenix, Inc. |
Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
|
EP1625162A2
(en)
|
2003-05-06 |
2006-02-15 |
Albert Einstein College Of Medicine Of Yeshiva University |
Compositions and methods for treatment of cryptococcosis
|
CA2525120C
(en)
|
2003-05-14 |
2013-04-30 |
Domantis Limited |
A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
|
JP4999158B2
(ja)
|
2003-05-21 |
2012-08-15 |
メダレツクス・インコーポレーテツド |
炭疽菌(bachillusanthracis)の感染防御抗原に対するヒトモノクローナル抗体
|
WO2004108078A2
(en)
|
2003-06-02 |
2004-12-16 |
Alexion Pharmaceuticals Inc. |
Rationally designed antibodies
|
EA013614B1
(ru)
|
2003-07-15 |
2010-06-30 |
Амджен Инк. |
Изолированное антитело к фактору роста нервов (ngf) и способы его применения
|
UY28424A1
(es)
*
|
2003-07-22 |
2005-02-28 |
Schering Ag |
Anticuerpos rgi y usos de los mismos.
|
HN2004000285A
(es)
*
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
JP2007528720A
(ja)
|
2003-08-12 |
2007-10-18 |
ダイアックス コーポレイション |
Tie1結合リガンド
|
WO2005019270A2
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
AR045563A1
(es)
*
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
WO2005034733A2
(en)
|
2003-10-08 |
2005-04-21 |
North Shore-Long Island Jewish Research Institute |
Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
|
CN1886426A
(zh)
|
2003-11-07 |
2006-12-27 |
伊姆尼斯公司 |
结合白细胞介素-4受体的抗体
|
CA2543631A1
(en)
|
2003-11-07 |
2005-05-26 |
Amgen Inc. |
Monkey immunoglobulin sequences
|
JP4870348B2
(ja)
|
2003-12-04 |
2012-02-08 |
株式会社ペルセウスプロテオミクス |
細胞表面抗原に対する抗体取得とその抗原同定
|
HUE035520T2
(en)
|
2003-12-10 |
2018-05-28 |
Squibb & Sons Llc |
Interferon alpha antibodies and their use
|
US20050191293A1
(en)
|
2003-12-10 |
2005-09-01 |
Shrikant Deshpande |
IP-10 antibodies and their uses
|
JP4712724B2
(ja)
|
2003-12-23 |
2011-06-29 |
クルセル ホランド ベー ヴェー |
CD1aに対するヒト結合分子
|
PT2311873T
(pt)
|
2004-01-07 |
2018-11-20 |
Novartis Vaccines & Diagnostics Inc |
Anticorpo monoclonal específico para m-csf e respetivos usos
|
CA2553946C
(en)
|
2004-02-06 |
2019-02-26 |
University Of Massachusetts |
Antibodies against clostridium difficile toxins and uses thereof
|
US7271245B2
(en)
|
2004-02-13 |
2007-09-18 |
The Scripps Research Institute |
Methods and compositions for inhibition of metastasis
|
WO2005086713A2
(en)
|
2004-03-04 |
2005-09-22 |
Kirin Brewery Co., Ltd. |
Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
|
US20050260679A1
(en)
|
2004-03-19 |
2005-11-24 |
Sirid-Aimee Kellerman |
Reducing the risk of human anti-human antibodies through V gene manipulation
|
RU2368622C2
(ru)
*
|
2004-04-13 |
2009-09-27 |
Ф.Хоффманн-Ля Рош Аг |
Антитела к р-селектину
|
WO2005109266A1
(en)
|
2004-05-07 |
2005-11-17 |
Snap-On Incorporated |
Tool monitoring system
|
WO2006014498A2
(en)
|
2004-07-06 |
2006-02-09 |
Bioren, Inc. |
Universal antibody libraries
|
EP1786918A4
(en)
|
2004-07-17 |
2009-02-11 |
Imclone Systems Inc |
NEW BISPECIFIC ANTIBODY TETRAVALENT
|
WO2006007850A1
(en)
|
2004-07-20 |
2006-01-26 |
Symphogen A/S |
Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
|
JP2008515774A
(ja)
|
2004-08-03 |
2008-05-15 |
ダイアックス コーポレイション |
hK1結合タンパク質
|
WO2006017759A2
(en)
|
2004-08-05 |
2006-02-16 |
Kirin Brewery Co., Ltd. |
Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
AU2005272848A1
(en)
|
2004-08-12 |
2006-02-23 |
Dyax Corp. |
Tie complex binding proteins
|
EP1791867A2
(en)
|
2004-08-23 |
2007-06-06 |
Genesto A/S |
Binding member towards pneumolysin
|
CA2580981C
(en)
|
2004-09-22 |
2013-10-22 |
Kirin Beer Kabushiki Kaisha |
Stabilized human igg4 antibodies
|
JP2008514730A
(ja)
|
2004-10-01 |
2008-05-08 |
メダレックス, インク. |
Cd30陽性リンパ腫の処置の方法
|
KR100619546B1
(ko)
|
2004-10-05 |
2006-09-04 |
아주대학교산학협력단 |
히스톤 h2a 및/또는 h2b에 대한 인간 모노클로날자가항체 및 그 단편
|
EP2377555A3
(en)
|
2004-11-18 |
2011-11-23 |
Imclone LLC |
Antibodies against vascular endothelial growth factor receptor-1
|
JP2008521411A
(ja)
|
2004-11-30 |
2008-06-26 |
キュラジェン コーポレイション |
Gpnmbに対する抗体およびその使用
|
CA2595610C
(en)
*
|
2004-12-21 |
2013-03-05 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
TW200902555A
(en)
|
2005-01-03 |
2009-01-16 |
Hoffmann La Roche |
Antibodies against IL-13 receptor alpha 1 and uses thereof
|
AU2006208286A1
(en)
|
2005-01-26 |
2006-08-03 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
CA2598561C
(en)
|
2005-02-18 |
2014-01-21 |
Medarex, Inc. |
Monoclonal antibodies against cd30 lacking in fucosyl residues
|
JP2006249082A
(ja)
|
2005-03-08 |
2006-09-21 |
Pharmacia & Upjohn Co Llc |
低減レベルの内毒素を有する抗m−csf抗体組成物
|
AU2006220828A1
(en)
|
2005-03-08 |
2006-09-14 |
Pharmacia & Upjohn Company Llc |
Anti-MAdCAM antibody compositions
|
US7988971B2
(en)
|
2005-03-14 |
2011-08-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Human monoclonal antibodies against Hendra and Nipah viruses
|
AU2006230413B8
(en)
|
2005-03-31 |
2011-01-20 |
Xencor, Inc |
Fc variants with optimized properties
|
EP1874820A4
(en)
|
2005-04-20 |
2010-09-22 |
Amgen Fremont Inc |
HIGH AFFINE, COMPLETELY HUMAN MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-8 AND EPITOPES FOR SUCH ANTIBODIES
|
WO2006124269A2
(en)
|
2005-05-16 |
2006-11-23 |
Amgen Fremont Inc. |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
EA019344B1
(ru)
|
2005-07-01 |
2014-03-31 |
МЕДАРЕКС, Эл.Эл.Си. |
Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1) и их применения
|
EP1913028B1
(en)
|
2005-07-28 |
2015-03-04 |
Novartis AG |
Use of antibody to m-csf
|
JP5457671B2
(ja)
|
2005-07-28 |
2014-04-02 |
ノバルティス アーゲー |
M−csf特異的モノクローナル抗体およびその使用
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
CA2621371C
(en)
*
|
2005-09-07 |
2018-05-15 |
Amgen Fremont Inc. |
Human monoclonal antibodies to activin receptor-like kinase-1
|
PT2655357T
(pt)
|
2010-12-20 |
2016-09-28 |
Merck Serono Sa |
Derivados indazolil-triazol como inibidores de irak
|
KR101460477B1
(ko)
|
2013-06-18 |
2014-11-10 |
주식회사 엘지화학 |
연신 적층체, 박형 편광자의 제조 방법, 이를 이용하여 제조되는 박형 편광자 및 이를 포함하는 편광판
|
JP6319584B2
(ja)
|
2015-02-27 |
2018-05-09 |
京セラドキュメントソリューションズ株式会社 |
画像形成システム
|